These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12915403)

  • 1. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
    Phillips RM; Six DA; Dennis EA; Ghosh P
    J Biol Chem; 2003 Oct; 278(42):41326-32. PubMed ID: 12915403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.
    Lee VT; Pukatzki S; Sato H; Kikawada E; Kazimirova AA; Huang J; Li X; Arm JP; Frank DW; Lory S
    Infect Immun; 2007 Mar; 75(3):1089-98. PubMed ID: 17178785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.
    Sato H; Frank DW; Hillard CJ; Feix JB; Pankhaniya RR; Moriyama K; Finck-Barbançon V; Buchaklian A; Lei M; Long RM; Wiener-Kronish J; Sawa T
    EMBO J; 2003 Jun; 22(12):2959-69. PubMed ID: 12805211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
    Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
    Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.
    Zhang A; Veesenmeyer JL; Hauser AR
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
    Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
    Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.
    Tyson GH; Hauser AR
    Infect Immun; 2013 Aug; 81(8):2873-81. PubMed ID: 23716613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A
    Tessmer MH; Anderson DM; Buchaklian A; Frank DW; Feix JB
    J Biol Chem; 2017 Feb; 292(8):3411-3419. PubMed ID: 28069812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.
    Rabin SD; Hauser AR
    Infect Immun; 2005 Jan; 73(1):573-82. PubMed ID: 15618197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.
    Anderson DM; Feix JB; Monroe AL; Peterson FC; Volkman BF; Haas AL; Frank DW
    J Biol Chem; 2013 Sep; 288(37):26741-52. PubMed ID: 23908356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.
    Ramirez JC; Fleiszig SM; Sullivan AB; Tam C; Borazjani R; Evans DJ
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):448-53. PubMed ID: 22167094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbing.
    Sato H; Frank DW
    PLoS One; 2014; 9(7):e103127. PubMed ID: 25061861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the effector ExoU from
    Springer TI; Reid TE; Gies SL; Feix JB
    J Biol Chem; 2019 Dec; 294(50):19012-19021. PubMed ID: 31662432
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases.
    Tessmer MH; Anderson DM; Pickrum AM; Riegert MO; Frank DW
    J Bacteriol; 2019 Feb; 201(4):. PubMed ID: 30455285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.
    Tyson GH; Halavaty AS; Kim H; Geissler B; Agard M; Satchell KJ; Cho W; Anderson WF; Hauser AR
    J Biol Chem; 2015 Jan; 290(5):2919-37. PubMed ID: 25505182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase A2 functions in Pseudomonas aeruginosa-induced apoptosis.
    Kirschnek S; Gulbins E
    Infect Immun; 2006 Feb; 74(2):850-60. PubMed ID: 16428727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.
    Rabin SD; Veesenmeyer JL; Bieging KT; Hauser AR
    Infect Immun; 2006 May; 74(5):2552-61. PubMed ID: 16622190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation.
    Atsumi G; Tajima M; Hadano A; Nakatani Y; Murakami M; Kudo I
    J Biol Chem; 1998 May; 273(22):13870-7. PubMed ID: 9593733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase A2 from rat pancreatic islets. Comparison of the expressed activity with that of an islet group VI cytosolic Ca2+-independent phospholipase A2.
    Ma Z; Ramanadham S; Hu Z; Turk J
    Biochim Biophys Acta; 1998 Apr; 1391(3):384-400. PubMed ID: 9555100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.